Current evaluation of the clinical, diagnostic, and therapeutic usefulness of prv-1 and c-mpl markers in polycythemia vera and essential thrombocythemia.
Pahl
Heike L
HL
Center for Clinical Research, University Hospital Freiburg.
D015415:Biomarkers; D005069:Evaluation Studies as Topic; D058851:GPI-Linked Proteins; D005786:Gene Expression Regulation; D006098:Granulocytes / Q000737:chemistry; D006801:Humans; D007391:International Cooperation; D007519:Isoantigens / Q000097:blood*; D008562:Membrane Glycoproteins / Q000097:blood*; D011087:Polycythemia Vera / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D012333:RNA, Messenger / Q000096:biosynthesis; D011956:Receptors, Cell Surface / Q000097:blood*; D053628:Receptors, Thrombopoietin / Q000097:blood*; D012189:Retrospective Studies; D013920:Thrombocythemia, Essential / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics
D015415:Biomarkers; C407242:CD177 protein, human; D058851:GPI-Linked Proteins; D007519:Isoantigens; D008562:Membrane Glycoproteins; D012333:RNA, Messenger; D011956:Receptors, Cell Surface; D053628:Receptors, Thrombopoietin; C082218:MPL protein, human